시장보고서 | 연간정보서비스 | 맞춤형시장조사 | 메일링 | 샘플 요청 목록
세계의 혈소판 시장 보고서(2025년)
Blood Platelets Global Market Report 2025
상품코드 : 1750929
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 175 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ￦ 6,487,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,490 ￦ 9,376,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,490 ￦ 12,266,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

혈소판 시장 규모는 향후 수년간 강력한 성장이 전망될 예정입니다. 예측 기간 동안의 성장은 외상 사례의 증가, 혈액 은행 수의 증가, 동종 수혈 요법에 대한 선호 증가, 인구 고령화, 상처 치유에 있어 혈소판의 필요성 증가에 기인할 수 있습니다. 이 기간에 예상되는 주요 동향에는 자동 혈소판 아페레시스 시스템의 개발, 혈소판 보존 기술의 발전, 혈소판을 풍부하게 포함하는 혈장(PRP) 요법, 백혈구 환원 혈소판으로의 전환, 인공 혈소판 대체물의 출현, 혈소판 장애의 유전자 편집, 자동 기증자 스크리닝 등이 있습니다.

혈액 질환의 유병률 증가는 혈소판 시장의 확대를 촉진할 것으로 예측됩니다. 이러한 질환의 유병률이 증가하는 것은 주로 고령 인구에 기인합니다. 나이에 따른 골수 기능의 자연적인 저하에 의해 고령자는 빈혈, 혈소판 감소증, 응고 장애 등의 상태에 빠지기 쉬워지기 때문입니다. 예를 들어, 2024년 4월, 호주에 본부를 두는 비영리 단체 퍼스 혈액 연구소는 혈액응고 인자의 부족으로 혈액이 잘 굳어지지 않는 드문 유전성 질환인 혈우병으로 진단받은 사람의 수가 2021년 23만 3,577명에서 2022년에는 25만 7,146명에 달했다고 보고했습니다.

혈액 혈소판 시장의 주요 기업은 보존 기간을 연장하고 가용성을 향상시키고 수혈 수요 증가에 대응하는 혈액 센터를 지원하기 위해 혈소판 풀링과 같은 혁신적인 솔루션 개발에 주력하고 있습니다. 혈소판 풀링은 여러 전혈 헌혈에서 얻은 혈소판을 결합하여 수혈용 단일 혈소판 단위를 만들고 혈액 공급 관리에서 가용성, 효율성 및 자원 사용을 개선합니다. 예를 들어, 2023년 2월, 미국 의료기술기업인 테르모 블러드 앤 셀 테크놀로지스는 미국 식품의약국(FDA)의 인가를 받아 IMUGARD WB 혈소판 풀링 세트를 출시했습니다. 이 기술 혁신은 전혈 유래 혈소판의 보존 기간을 5일에서 7일로 연장하여 수혈용 혈소판의 가용성을 향상시킵니다. 또한 수요 증가와 기증자 부족에 대응하기 위한 대체 혈소판 공급을 제공하여 혈액 센터가 재고 관리를 강화하고 낭비를 줄일 수 있습니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 - 금리, 인플레이션, 지정학, 무역전쟁과 관세, 코로나 태와 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

제6장 시장 세분화

제7장 지역별/국가별 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 프로파일

제31장 기타 주요 기업 및 혁신 기업

제32장 세계 시장 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병(M&A)

제34장 최근 시장 동향

제35장 시장의 잠재력이 높은 국가, 부문, 전략

제36장 부록

SHW
영문 목차

영문목차

Blood platelets, also known as thrombocytes, are small, disc-shaped cell fragments found in the blood that play a crucial role in clot formation and wound healing. They prevent excessive bleeding by adhering to damaged blood vessel walls, aggregating with other platelets, and releasing clotting factors to stabilize the clot and prevent significant blood loss. Produced in the bone marrow, platelets are vital for hemostasis and blood vessel repair.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The main types of platelets in the blood platelet market are whole blood-derived platelets and apheresis-derived platelets. Whole blood-derived platelets are obtained by separating platelets from a standard whole blood donation, often pooled from multiple donors for transfusion. These platelets are used for treating platelet function disorders, hemophilia, thrombocytopenia, and perioperative indications. The primary end-users of these platelets include hospitals, ambulatory surgical centers, blood banks, research laboratories, specialty clinics, cancer treatment centers, trauma centers, and others.

The blood platelets market research report is one of a series of new reports from The Business Research Company that provides blood platelets market statistics, including blood platelets industry global market size, regional shares, competitors with a blood platelets market share, detailed blood platelets market segments, market trends and opportunities, and any further data you may need to thrive in the blood platelets industry. This blood platelets market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The blood platelets market size has grown strongly in recent years. It will grow from$6.27 billion in 2024 to $6.72 billion in 2025 at a compound annual growth rate (CAGR) of 7.2%. The growth during the historic period can be attributed to the increasing number of surgeries, the rising incidence of traumatic injuries, the 6.27% prevalence of autoimmune diseases, the growing incidence of chronic diseases, and the increasing prevalence of thrombocytopenia.

The blood platelets market size is expected to see strong growth in the next few years. It will grow to$8.79 billion in 2029 at a compound annual growth rate (CAGR) of 6.9%. The growth during the forecast period can be attributed to the increasing number of trauma cases, the rise in the number of blood banks, a growing preference for allogeneic blood transfusion therapies, the aging population, and the increasing need for platelets in wound healing. Key trends expected during this period include the development of automated platelet apheresis systems, advancements in platelet storage technologies, platelet-rich plasma (PRP) therapies, a shift toward leukoreduced platelets, the emergence of artificial platelet substitutes, gene editing for platelet disorders, and automated donor screening.

The growing prevalence of blood disorders is expected to propel the expansion of the blood platelets market. Blood disorders refer to conditions that impact the function, production, or components of blood, including red blood cells, white blood cells, platelets, or plasma, leading to issues such as anemia, clotting disorders, or immune system deficiencies. The increasing prevalence of these disorders is largely due to the aging population, as the natural decline in bone marrow function with age makes older adults more vulnerable to conditions such as anemia, thrombocytopenia, and clotting disorders. Blood platelets are crucial in the treatment of blood disorders, as they regulate blood clotting, preventing excessive bleeding and supporting wound healing. For example, in April 2024, the Perth Blood Institute, a non-profit organization based in Australia, reported that the number of people diagnosed with hemophilia, a rare genetic disorder where blood doesn't clot properly due to a lack of clotting factors, reached 257,146 in 2022, up from 233,577 in 2021. Therefore, the rising prevalence of blood disorders is significantly contributing to the growth of the blood platelets market.

Major players in the blood platelet market are focusing on developing innovative solutions such as platelet pooling to extend shelf life, improve availability, and assist blood centers in meeting the increasing demand for transfusions. Platelet pooling involves combining platelets from multiple whole blood donations to create a single platelet unit for transfusion, thereby improving availability, efficiency, and resource utilization in blood supply management. For instance, in February 2023, Terumo Blood and Cell Technologies, a US-based medical technology company, launched the IMUGARD WB platelet pooling set after receiving U.S. Food and Drug Administration (FDA) clearance. This innovation extends the shelf life of whole blood-derived platelets from five to seven days, improving platelet availability for transfusion. It also offers an alternative platelet supply to address rising demand and donor shortages, helping blood centers enhance inventory management and reduce waste.

In December 2023, Sysmex Corporation, a Japan-based healthcare and diagnostics company, increased its stake in Megakaryon Corporation for an undisclosed amount. With this acquisition, Sysmex aims to accelerate the commercialization of high-quality, induced pluripotent stem (iPS) cell-derived platelets by utilizing Megakaryon's technology, strengthening synergies within the group, and advancing regenerative medicine through automation and quality control innovations. Megakaryon Corporation, a Japan-based biotechnology company, specializes in the production of iPS cell-derived platelets for safer and more sustainable blood transfusions.

Major players in the blood platelets market are Pfizer Inc., Johnson & Johnson, Bayer AG, Fresenius Kabi, Takeda Pharmaceutical Company Limited, Baxter International Inc., CSL Limited, Grifols S.A., Terumo Corporation, American Red Cross, BioMarin Pharmaceutical Inc., Miltenyi Biotec, Kedrion Biopharma Inc., LFB Group, Bio Products Laboratory Limited, Sanquin, Macopharma, Biotest AG, Cerus Corporation, ADMA Biologics Inc., Octapharma AG, Kamada Ltd., and HemaCare.

North America was the largest region in the blood platelets market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in blood platelets report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the blood platelets market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The blood platelets market consists of sales of platelet apheresis kits, platelet storage systems, platelet-derived growth factors (PDGFs), platelet function analyzers and platelet transfusion services. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Blood Platelets Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on blood platelets market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for blood platelets ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The blood platelets market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Scope

Table of Contents

1. Executive Summary

2. Blood Platelets Market Characteristics

3. Blood Platelets Market Trends And Strategies

4. Blood Platelets Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Blood Platelets Growth Analysis And Strategic Analysis Framework

6. Blood Platelets Market Segmentation

7. Blood Platelets Market Regional And Country Analysis

8. Asia-Pacific Blood Platelets Market

9. China Blood Platelets Market

10. India Blood Platelets Market

11. Japan Blood Platelets Market

12. Australia Blood Platelets Market

13. Indonesia Blood Platelets Market

14. South Korea Blood Platelets Market

15. Western Europe Blood Platelets Market

16. UK Blood Platelets Market

17. Germany Blood Platelets Market

18. France Blood Platelets Market

19. Italy Blood Platelets Market

20. Spain Blood Platelets Market

21. Eastern Europe Blood Platelets Market

22. Russia Blood Platelets Market

23. North America Blood Platelets Market

24. USA Blood Platelets Market

25. Canada Blood Platelets Market

26. South America Blood Platelets Market

27. Brazil Blood Platelets Market

28. Middle East Blood Platelets Market

29. Africa Blood Platelets Market

30. Blood Platelets Market Competitive Landscape And Company Profiles

31. Blood Platelets Market Other Major And Innovative Companies

32. Global Blood Platelets Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Blood Platelets Market

34. Recent Developments In The Blood Platelets Market

35. Blood Platelets Market High Potential Countries, Segments and Strategies

36. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기